XML 73 R2.htm IDEA: XBRL DOCUMENT v3.19.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Total revenues $ 14,229 $ 19,826 $ 48,220 $ 82,349
Operating expenses:        
Cost of products 2,823 3,120 9,711 13,224
Research and development expenses 7,539 11,402 25,160 33,243
Selling, general and administrative expenses 5,316 24,829 22,520 77,159
Intangible asset amortization 205 1,620 610 4,996
Changes in fair value of related party contingent consideration 627 (7,115) 2,384 (17,036)
Restructuring costs 1,866 65 4,600 268
Total operating expenses 18,376 33,921 64,985 111,854
Operating loss (4,147) (14,095) (16,765) (29,505)
Investment and other income, net 781 208 2,548 845
Interest expense (3,125) (3,000) (9,293) (7,577)
Loss on deconsolidation of subsidiary 0 0 (2,840) 0
Other (expense) income - changes in fair value of related party payable (139) 425 (496) 1,432
Loss before income taxes (6,630) (16,462) (26,846) (34,805)
Income tax provision (benefit) 2,234 (691) 3,641 (3,360)
Net loss $ (8,864) $ (15,771) $ (30,487) $ (31,445)
Net income (loss) per share - basic (in dollars per share) $ (0.24) $ (0.43) $ (0.82) $ (0.84)
Net income (loss) per share - diluted (in dollars per share) $ (0.24) $ (0.43) $ (0.82) $ (0.84)
Weighted average number of shares outstanding - basic (in shares) 37,436 36,904 37,382 37,410
Weighted average number of shares outstanding - diluted (in shares) 37,436 36,904 37,382 37,410
Product sales        
Revenues:        
Total revenues $ 14,229 $ 19,826 $ 48,220 $ 82,103
License revenue        
Revenues:        
Total revenues $ 0 $ 0 $ 0 $ 246